Deciphera Pharmaceuticals

#DidYouKnow that nearly 1 in 4 cancer diagnoses is rare? September 30th marks #RareCancerDay, an annual awareness day devoted to shining a light on rare cancers like #GIST. Learn more about the National Organization for Rare Disorders and the Rare Cancer Day initiative here: https://lnkd.in/eh2gwb8J

Our Lawrence, KS office is growing! We’re seeking a Director of Biological Sciences to join our oncology #drugdiscovery group. If you’re collaborative, driven, and a strategic problem-solver, apply here: https://lnkd.in/eBK9bg4J #Hiring #PharmaJobs

Behind our extensive oncology pipeline is a talented group of scientists, clinicians, and researchers dedicated to delivering transformational medicines that have a meaningful impact on patients. We’re excited about what we’ve achieved so far in #cancerresearch, and look forward to continuing to raise the bar for patients in #oncology. #WorldCancerResearchDay Learn more about our work: https://www.deciphera.com/

We are excited about the recent European Commission approval of our new medicine for people living with tenosynovial giant cell tumor (#TGCT)! Learn more: https://lnkd.in/ed5zs6sQ #CancerResearch

We’re proud to announce the European Commission approval of our medicine for patients with symptomatic tenosynovial giant cell tumor (#TGCT) associated with clinically relevant physical function deterioration and in whom surgical options have been exhausted or would induce unacceptable morbidity or disability. Learn more at our press release here: https://lnkd.in/ed5zs6sQ

Are you a clinical supply chain expert with experience in leading a team? We’re looking for a Director of Clinical Supply Chain to join us in Waltham and aid in our mission to deliver transformational medicines to patients. Read the full job description here: https://lnkd.in/eBK9bg4J #Hiring #SupplyChain #PharmaJobs

It’s been an exciting summer here at Deciphera as we welcomed our colleagues from Ono Pharma USA to our office in Waltham, Massachusetts. Our combined team is more passionate and driven than ever about developing transformational medicines for patients. To our new teammates, welcome! We’re glad to have you with us and can’t wait to see what we accomplish together.

Patients with tenosynovial giant cell tumor (#TGCT) can experience substantial symptomatic burdens including pain and stiffness, impaired physical function and limited range of motion, which negatively impacts quality of life.     Learn more about Deciphera’s commitment to advancing research in this disease: https://bit.ly/3UFuTvm 

Join our team! We’re looking for a Senior Director of Program Leadership to join us in Waltham, MA. This candidate will be a strategic leader who can leverage their strong oncology drug development expertise, EQ, and organizational skills to drive and execute the integrated program strategy. Learn more about the position here: https://lnkd.in/ezTpCUvu

Today, ONO PHARMACEUTICAL CO., LTD., the parent company of Deciphera, announced its financial results for the first quarter 2025. Read more: https://bit.ly/47bE4Lw